M. Madorin et al., ANALYSIS OF DRUG PLASMA-PROTEIN INTERACTIONS BY MEANS OF ASYMMETRICALFLOW-FIELD FLOW FRACTIONATION, Pharmaceutical research, 14(12), 1997, pp. 1706-1712
Purpose, The applicability of Asymmetrical Flow Field-Flow Fractionati
on (Asymmetrical Flow FFF) as an alternative tool to examine the distr
ibution of a lipophilic drug (N-Benzoyl-staurosporine) within human pl
asma protein fractions was investigated with respect to high separatio
n speed and loss of material on surfaces due to adsorption. Methods. F
ield-Flow Fractionation is defined as a group of pseudochromatographic
separation methods, where compounds are separated under the influence
of an externally applied force based on differences in their physicoc
hemical properties. This method was used to separate human plasma in i
ts protein fractions. The drug distribution in the fractions was inves
tigated by monitoring the fractionated eluate for drug content by fluo
rescence spectroscopy. Results. Human plasma was separated into human
serum albumin (HSA), high density lipoprotein (HDL), alpha(2)-macroglo
bulin and low density lipoprotein (LDL) fractions in less than ten min
utes. Calibration of the system and identification of the individual f
ractions was performed using commercially available protein reference
standards. The influence of membrane type and carrier solution composi
tion on the absolute recovery of N-Benzoyl-staurosporine and fluoresce
in-isothiocyanate-albumin (FITC-albumin) was found to be quite signifi
cant. Both factors were-optimized during the course of the investigati
ons. N-Benzoyl-staurosporine was found to be enriched in the fraction
containing HSA. Conclusions. If experimental conditions are thoroughly
selected and controlled to suppress drug and plasma protein adsorptio
n at the separation membrane, Asymmetrical Flow FFF shows high recover
ies and fast separation of human plasma proteins, and can be a reliabl
e tool to characterize drug / plasma protein interactions. For analyti
cal purposes it has the potential to rival established technologies li
ke ultracentrifugation in terms of ease-of-use, precision, and separat
ion time.